We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+16.06%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.88B
AUM Growth
+$967M
Cap. Flow
-$59.3M
Cap. Flow %
-0.75%
Top 10 Hldgs %
72.68%
Holding
127
New
5
Increased
26
Reduced
38
Closed
14

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$343M
2
LIVN icon
LivaNova
LIVN
+$7.76M
3
TAK icon
Takeda Pharmaceutical
TAK
+$7.37M
4
ILMN icon
Illumina
ILMN
+$4.35M
5
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$4.26M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$330M
2
V icon
Visa
V
+$15.4M
3
HDB icon
HDFC Bank
HDB
+$9.39M
4
TMO icon
Thermo Fisher Scientific
TMO
+$8.95M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.16M

Sector Composition

Rank Sector Weight
1 Financials 22.43%
2 Consumer Discretionary 16.91%
3 Healthcare 14.47%
4 Consumer Staples 10.11%
5 Communication Services 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$322B
$27.4M 0.35%
345,793
– –
BHVN
27
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$19.6M 0.25%
381,751
+83,001
+28% +$3.59M
AMRN
28
Amarin Corp
AMRN
$297M
$15.8M 0.2%
38,066
+6,423
+20% +$2.32M
AMGN icon
29
Amgen
AMGN
$209B
$15.3M 0.19%
80,787
-29,929
-27% -$5.72M
HCA icon
30
HCA Healthcare
HCA
$90.6B
$14.7M 0.19%
112,905
+20,178
+22% +$2.71M
BSX icon
31
Boston Scientific
BSX
$68.4B
$14.1M 0.18%
367,194
– –
BDX icon
32
Becton Dickinson
BDX
$46.4B
$13.2M 0.17%
54,279
– –
GILD icon
33
Gilead Sciences
GILD
$165B
$12.8M 0.16%
196,598
-11,093
-5% -$737K
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$123B
$12.6M 0.16%
68,557
-4,780
-7% -$883K
LLY icon
35
Eli Lilly
LLY
$1.08T
$11.9M 0.15%
91,848
– –
AGN
36
DELISTED
Allergan plc
AGN
$11.1M 0.14%
75,890
– –
ABBV icon
37
AbbVie
ABBV
$465B
$10.1M 0.13%
125,780
– –
CNC icon
38
Centene
CNC
$30.5B
$9.95M 0.13%
187,306
– –
BIIB icon
39
Biogen
BIIB
$30.9B
$9.82M 0.12%
41,551
-2,614
-6% -$823K
HOLX
40
DELISTED
Hologic
HOLX
$9.65M 0.12%
199,328
– –
CELG
41
DELISTED
Celgene Corp
CELG
$9.24M 0.12%
97,986
-28,564
-23% -$2.5M
EW icon
42
Edwards Lifesciences
EW
$49.4B
$8.79M 0.11%
137,829
– –
LIVN icon
43
LivaNova
LIVN
$4.47B
$8.09M 0.1%
+83,163
New +$7.76M
ISRG icon
44
Intuitive Surgical
ISRG
$127B
$7.5M 0.1%
39,411
+22,995
+140% +$4.09M
TAK icon
45
Takeda Pharmaceutical
TAK
$56.7B
$7.46M 0.09%
+366,380
New +$7.37M
VTRS icon
46
Viatris
VTRS
$20.8B
$7.3M 0.09%
257,473
– –
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$6.47M 0.08%
136,142
+55,127
+68% +$2.43M
ALXN
48
DELISTED
Alexion Pharmaceuticals
ALXN
$6.4M 0.08%
47,325
-4,275
-8% -$532K
HRTX icon
49
Heron Therapeutics
HRTX
$93.4M
$6.16M 0.08%
252,069
+120,471
+92% +$3.15M
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$11.9B
$6.12M 0.08%
68,851
– –
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2019 Portfolio in Review

As of Q1 2019, C WorldWide Group held 127 positions worth $7.88B, up 14% from $6.91B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group's Q1 2019 filing shows 5 new, 26 increased, 38 reduced and 14 closed positions. Its largest new stake was LivaNova: 83,163 shares worth $8.09M. The largest sale was Meta Platforms (Facebook), an estimated $330M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q1 2019 buy was LivaNova: 83,163 shares worth $8.09M.
  • C WorldWide Group added most to Microsoft in Q1 2019, an estimated $343M increase.
  • C WorldWide Group's biggest Q1 2019 reduction was Visa, cutting an estimated $15.4M.
  • C WorldWide Group fully exited Meta Platforms (Facebook) in Q1 2019, selling an estimated $330M.
  • C WorldWide Group's ten largest holdings make up 73% of its $7.88B portfolio in Q1 2019.
  • C WorldWide Group opened 5 new positions and closed 14 in Q1 2019.
  • C WorldWide Group's portfolio value rose 14% quarter-over-quarter to $7.88B.

Based on C WorldWide Group's 13F filing for Q1 2019, filed 3 May 2019.